Neuland Laboratories Limited (BOM:524558)
India · Delayed Price · Currency is INR 12,960
-219 (-1.66%)
At close: Feb 12, 2026
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 167.35 billion as of February 13, 2026. Its market cap has decreased by -3.54% in one year.
Market Cap
167.35B
Enterprise Value
168.31B
Revenue
15.75B
Ranking
n/a
PE Ratio
93.42
Stock Price
12,960.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 167.35B, an increase of 49,834.57%. That is a compound annual growth rate of 28.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 167.35B | -14.13% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sudeep Pharma | 75.92B |
| Shilpa Medicare | 63.23B |
| Suven Life Sciences | 35.30B |
| Gujarat Themis Biosyn | 34.84B |
| IOL Chemicals and Pharmaceuticals | 21.85B |
| NGL Fine-Chem | 13.84B |
| Bajaj HealthCare | 11.59B |
| Shree Ganesh Remedies | 6.59B |